Proven EAAs Guava Nectarine
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 27% of ingredients have research evidence
B
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
13 Gram(s)
Serving Size
6
Servings
Non-Nutrient/Non-Botanical
Product Type
27%
Evidence Coverage
Supplement Facts — Evidence Check
Calories
40 Calorie(s)
Total Fat
Cholesterol
Sodium
30 mg
(1% DV)
Total Carbohydrates
Protein
9 Gram(s)
(18% DV)
Calcium
40 mg
(4% DV)
20 mg
(5% DV)
📊 Market median: 4002.0mg (1 products)
📚 20 studies (Tier A: 0, B: 2)
📊 Market median: 500.0mg (180 products)
📚 5 studies (Tier A: 0, B: 1)
3 Gram(s)
📊 Market median: 500.0mg (180 products)
📚 5 studies (Tier A: 0, B: 1)
Electrolyte Blend
600 mg
Other Ingredients
Citric Acid
Malic Acid
Natural & Artificial Guava Nectarine flavor
Silica
Sucralose
Acesulfame Potassium
Turmeric root powder
Label Claims — Verification
❓
Nutrient
❓
All Other
❓
Structure/Function
All Other (98% of products)
Structure/Function (78% of products)
Nutrient (56% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Suggested Use: As a dietary supplement, take 3 scoops of Proven EAAs before workout with 10 oz. of water or juice or as directed by a practitioner.
⚠️ Warnings & Precautions
Warning: Cancer and reproductive harm - www.P65Warnings.ca.gov
🧪 Formulation Notes
Full spectrum of 9 essential amino acids Leucine heavy ratio of branched chain amino acids 4:1:1 Electrolyte matrix Himalayan pink salt delivering sodium, potassium, magnesium, & calcium.
Proven EAAs with 9 essential amino acids 6 g vegan fermented BCAAs 9 total essential amino acids Naturally & artificially flavored Guava Nectarine
Non GMO
Great taste
Made in the USA from domestic and international ingredients.
Product Details
UPC / SKU
6 46511 02764 0
DSLD Entry Date
2020-06-24
Product Type
Non-Nutrient/Non-Botanical
Form
Powder
Brand
Gaspari Nutrition
DSLD ID
228122
Data Updated
2026-04-11
Research Evidence
50
Research Sources
47
Avg Quality Score
28
Rct
13
Clinical Trial
5
Guideline
4
Systematic Review
A
Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors.
B
Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors.
B
Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates
B
[Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)].
B
[Chinese expert consensus on epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer (2025 edition)].
B
Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.
B
Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating
C
Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-analysis with Meta-regression
Compare Similar Products
Pure L-Tyrosine Free Form Amino Powder
Hard Rhino
100
100% Pure L-Tyrosine
NutraBio
100
N-Acetyl L-Tyrosine
NutraBio
100
N-Acetyl L-Tyrosine
NutraBio
100
L-Tyrosine
Hard Rhino
100